Symbols

TEVA

Teva Pharmaceutical·NYSE

--(--)

6.04 / 10

Outperform

Analyst consensus is split: 50% Strong Buy, 50% Buy, no holds. Sentiment scores 6.04/10 (Outperform). Fund‑flow rating is good (7.56), with ~46% overall inflow but negative trends across all size blocks. Price fell 8.79%, tempering optimism.

Fund Flow Rating

Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

50%

Buy

50%

Hold

Sell

Strong Sell

Date2026-03-04

InstitutionPiper Sandler

Times predicted2

Historical Win Rate50.0%

What is the market sentiment for TEVA?

TEVA holds a Bearish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.04/10 (Outperform).